BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 10942234)

  • 1. Combination of interferon alpha with either Ara-C or ATRA in vitro reduces the selective action of interferon against CML CFU-GM.
    Marley SB; Davidson RJ; Goldman JM; Gordon MY
    Leukemia; 2000 Aug; 14(8):1396-400. PubMed ID: 10942234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. All-trans retinoic acid potentiates the inhibitory effects of interferon alpha on chronic myeloid leukemia progenitors in vitro.
    Mahon FX; Chahine H; Barbot C; Pigeonnier V; Jazwiec B; Reiffers J; Ripoche J
    Leukemia; 1997 May; 11(5):667-73. PubMed ID: 9180290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The tyrosine kinase inhibitor STI571, like interferon-alpha, preferentially reduces the capacity for amplification of granulocyte-macrophage progenitors from patients with chronic myeloid leukemia.
    Marley SB; Deininger MW; Davidson RJ; Goldman JM; Gordon MY
    Exp Hematol; 2000 May; 28(5):551-7. PubMed ID: 10812245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. All-trans retinoic acid combined with interferon-alpha effectively inhibits granulocyte-macrophage colony formation in chronic myeloid leukemia.
    Zheng A; Savolainen ER; Koistinen P
    Leuk Res; 1996 Mar; 20(3):243-8. PubMed ID: 8637219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment with interferon-alpha preferentially reduces the capacity for amplification of granulocyte-macrophage progenitors (CFU-GM) from patients with chronic myeloid leukemia but spares normal CFU-GM.
    Gordon MY; Marley SB; Lewis JL; Davidson RJ; Nguyen DX; Grand FH; Amos TA; Goldman JM
    J Clin Invest; 1998 Aug; 102(4):710-5. PubMed ID: 9710439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eilatin: a novel marine alkaloid inhibits in vitro proliferation of progenitor cells in chronic myeloid leukemia patients.
    Einat M; Lishner M; Amiel A; Nagler A; Yarkorli S; Rudi A; Kashman Y; Markel D; Fabian I
    Exp Hematol; 1995 Dec; 23(14):1439-44. PubMed ID: 8542929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of homoharringtonine alone and in combination with alpha interferon and cytosine arabinoside on 'in vitro' growth and induction of apoptosis in chronic myeloid leukemia and normal hematopoietic progenitors.
    Visani G; Russo D; Ottaviani E; Tosi P; Damiani D; Michelutti A; Manfroi S; Baccarani M; Tura S
    Leukemia; 1997 May; 11(5):624-8. PubMed ID: 9180282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of imatinib mesylate (STI571) used alone or in combination with purine nucleoside analogues on the normal and chronic myelogenous leukaemia progenitor cells in vitro.
    Korycka A; Robak T
    Leuk Lymphoma; 2003 Sep; 44(9):1549-55. PubMed ID: 14565659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The comparison of 2-chlorodeoxyadenosine (2-Cd A) in combination with interferon alpha (IFN alpha) or interferon gamma (IFN gamma) on granulocyte-macrophage progenitor cells (CFU-GM) and clonogenic blasts in (CFU-L) in vitro cultures.
    Robak T; Korycka A
    Leuk Lymphoma; 1996 Mar; 21(1-2):161-8. PubMed ID: 8907284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A differential sensitivity to recombinant human interferon-alpha 2a between normal and chronic myeloid leukaemic peripheral blood granulocyte-macrophage colony-forming units.
    Gronthos S; To LB; Haylock DN; Juttner CA
    Leuk Res; 1992; 16(2):153-8. PubMed ID: 1545568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unexpected high incidence of severe toxicities associated with alpha interferon, low-dose cytosine arabinoside and all-trans retinoic acid in patients with chronic myelogenous leukemia.
    Sacchi S; Kantarjian HM; Freireich EJ; O'Brien S; Cortes J; Rios MB; Kornblau S; Giles FJ; Koller C; Gajewski J; Talpaz M
    Leuk Lymphoma; 1999 Nov; 35(5-6):483-9. PubMed ID: 10609785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of cyclosporin A used alone and in combination with either 2-chlorodeoxyadenosine or fludarabine on normal and chronic myelogenous leukemia progenitors in vitro.
    Korycka A; Robak T
    Arch Immunol Ther Exp (Warsz); 2003; 51(1):61-7. PubMed ID: 12691305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effect of interferon alone, cytosine arabinoside alone and their combined effect on hematopoietic progenitors of chronic myeloid leukemia in vitro].
    Qin H; Yang Y; Liang Y; Li Y; Zeng L
    Hua Xi Yi Ke Da Xue Xue Bao; 2002 Apr; 33(2):281-4. PubMed ID: 12575210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of retinoic acid and interferon alpha on granulocyte-macrophage colony forming cells in chronic myeloid leukemia: increased inhibition by all-trans- and 13-cis-retinoic acids in advanced stage disease.
    Sagayadan GE; Wiernik PH; Sun N; Ahearn G; Thompson D; Hallam SJ; Hu XP; Dutcher JP; Gallagher RE
    Leuk Res; 1994 Oct; 18(10):741-8. PubMed ID: 7934131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon protects normal human granulocyte/macrophage colony-forming cells from Ara-C cytotoxicity.
    Richman CM; Slapak CA; Toh B
    J Biol Response Mod; 1990 Dec; 9(6):570-5. PubMed ID: 1705960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. All-trans retinoic acid potentiates megakaryocyte colony formation: in vitro and in vivo effects after administration to acute promyelocytic leukemia patients.
    Visani G; Zauli G; Tosi P; Ottaviani E; Gibellini D; Manfroi S; Celeghini C; Pagliarini C; Bassini A; Tura S
    Leukemia; 1994 Dec; 8(12):2183-7. PubMed ID: 7528859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon-alpha and bcr-abl antisense oligodeoxynucleotides in combination enhance the antileukemic effect and the adherence of CML progenitors to preformed stroma.
    Bellucci R; Sala R; De Propris MS; Cordone I; de Fabritiis P
    Leuk Lymphoma; 1999 Nov; 35(5-6):471-81. PubMed ID: 10609784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of "discordant maturation' in chronic myeloid leukaemia using cultures of primitive progenitor cells and their production of clonogenic progeny (CFU-GM).
    Marley SB; Lewis JL; Scott MA; Goldman JM; Gordon MY
    Br J Haematol; 1996 Nov; 95(2):299-305. PubMed ID: 8904885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant interferon-alpha-2C in chronic myelogenous leukaemia: relationship of sensitivity of committed haematopoietic precursor cells in vitro (BFU-E, CFU-GM, CFU-Meg) and clinical response.
    Geissler D; Gastl G; Aulitzky W; Tilg H; Gaggl S; Konwalinka G; Huber C
    Leuk Res; 1990; 14(7):629-36. PubMed ID: 2388474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro apoptotic response of freshly isolated chronic myeloid leukemia cells to all-trans retinoic acid and cytosine arabinoside.
    Stagno F; Guglielmo P; Consoli U; Inghilterra G; Giustolisi GM; Palumbo GA; Giustolisi R
    Acta Haematol; 2000; 104(2-3):57-64. PubMed ID: 11154976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.